FdaApplication
NDA 020763
Identifiers
- fda_app_no: NDA020763
Properties
| Property | Value |
|---|---|
| applicant_name | GLAXOSMITHKLINE LLC |
| application_type | NDA |
| approval_date | 1998-02-10 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AMERGE | NARATRIPTAN HYDROCHLORIDE | EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| AMERGE | NARATRIPTAN HYDROCHLORIDE | EQ 1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
2 products